MGRX
MANGOCEUTICALS, INC.
Key Financials
Gross Profit
$250386
↓ 34.1%
Net Income
$-20642994
↓ 137.1%
Revenue
$456021
↓ 26.0%
Operating Income
$-18032349
↓ 126.2%
EPS (Diluted)
$-2.17
↑ 55.2%
Shareholders' Equity
$15.2M
↑ 9.0%
Total Assets
$16.1M
↑ 4.7%
Total Liabilities
$890568.00
↓ 37.5%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 5/19/2026 | View on SEC |
| NT 10-Q | 5/15/2026 | View on SEC |
| 10-K | 4/1/2026 | View on SEC |
| NT 10-K | 3/31/2026 | View on SEC |
| 4 | 3/20/2026 | View on SEC |
| 4 | 3/20/2026 | View on SEC |
| 8-K | 3/17/2026 | View on SEC |
| 8-K | 2/23/2026 | View on SEC |
| 8-K | 2/19/2026 | View on SEC |
| 8-K | 2/6/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | MGRX |
| Company Name | MANGOCEUTICALS, INC. |
| CIK | 1938046 |
| Sector | Services-Misc Health & Allied Services, NEC |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 8090 |
| SIC Description | Services-Misc Health & Allied Services, NEC |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | TX |
| Phone | (833) 626-4679 |